Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Case of the day
    • Aspirin may induce...

    Aspirin may induce bullous pemphigoid : A case study

    Written by Hina Zahid Published On 2018-12-30T18:00:57+05:30  |  Updated On 30 Dec 2018 6:00 PM IST
    Aspirin may induce bullous pemphigoid : A case study

    Bullous pemphigoid is a chronic, most frequent acquired autoimmune blistering skin disease. Aspirin though notorious for causing allergic reactions is not known to usually induce bullous pemphigoid. Certain drugs such as furosemide, penicillins, sulfonamides, ciprofloxacin, penicillamines, angiotensin-converting enzyme inhibitors, chloroquine, and phenacetin have been reported to cause bullous pemphigoid.


    Dr Murat Durdu at Başkent University Faculty of Medicine, Department of Dermatology, Adana Hospital, Adana, Turkey and colleagues reported a case of bullous pemphigoid induced by aspirin. The case was reported in the Journal of the American Academy of Dermatology.


    A 76-year-old man with a 2-month history of recurrent blisters on his trunk and extremities was admitted to our hospital. He had been diagnosed with bullous pemphigoid (BP) and treated with methylprednisolone. Despite corticosteroid therapy, he continued to develop new bullae. He has been taking enalapril for hypertension for 2 years as well as aspirin and folic acid for essential thrombocytosis for 6 months.




    Multiple erosions on trunk (A); tense bullae and erosions on the back (B); vesicles on the wrist (C). Courtesy Journal of American Academy of dermatologists

    On admission, skin examination revealed several tense vesicles and bullae on the trunk and extremities as well as erosions on the buccal and gingival mucosa. Nikolskiy's sign was negative. Tzanck smear test did not show acantholytic cells. Histopathologic examination revealed a subepidermal bulla and a moderate inflammatory infiltrate composed of neutrophils and eosinophils in the upper dermis.


    Direct immunofluorescence (IF) test of the perilesional skin showed linear deposits of IgG and C3 along the dermoepidermal junction. Indirect IF test on monkey esophagus was positive. Indirect IF of salt-split skin showed IgG binding to the epidermal side of the specimen, confirming the diagnosis of BP. Oral methylprednisolone (48 mg/d) was started. Aspirin and folic acid were discontinued, and enalapril was switched to amlodipine.


    Five days of treatment stopped the formation of new blisters. However, the numerous blisters developed 1 day after reintroduction of aspirin for essential thrombocytosis. All of the lesions resolved completely in 10 days after aspirin had been withdrawn. Thus the diagnosis of aspirin-induced-BP was made. Patch testing could not be performed. Methylprednisolone was stopped after 2 months. No relapse of BP was observed in the follow-up period of 3 months.


    For more details click on the link: DOI: https://doi.org/10.1016/j.jaad.2010.02.032
    bullous pemphigoidcorticosteroid therapygingival mucosaIgGimmunofluorescencemethylprednisolone

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Hina Zahid
    Hina Zahid
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok